BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...
Is Compass Therapeutics (CMPX) The Hot Biotech Stock Under $5?
We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...